In line with these findings, it was shown that blocking LFA-1/ICAM-1 interaction with gene targeting strategies decreased CAR T-cell interaction with tumor cells as well as cytotoxicity and tumor growth control in mouse models (18, 21). The gene discussed is ITGB2; the disease is neoplasm.